APMD · NASDAQ
Apnimed (APMD) Stock Price & Fundamentals
Apnimed (APMD) closed at $491.84 on Oct 9, 2026, up 0.82% from the previous close of $487.86.
Share price, past year
1Y +17.70%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $491.84 |
| Sep 30, 2026 | $476.04 |
| Aug 31, 2026 | $478.14 |
| Jul 31, 2026 | $474.20 |
| Jun 30, 2026 | $469.70 |
| May 29, 2026 | $462.00 |
| Apr 30, 2026 | $431.64 |
| Mar 31, 2026 | $437.37 |
| Feb 27, 2026 | $447.33 |
| Jan 30, 2026 | $461.72 |
| Dec 31, 2025 | $457.09 |
| Nov 28, 2025 | $438.15 |
| Oct 31, 2025 | $428.10 |
Key statistics
- Market cap
- $20.48B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 41.6M
- Dividend yield
- —
- 52-week range
- $413.37 – $494.28
Apnimed's market cap is $20.48B, based on a share price of $491.84 and 41.6M shares outstanding as of Sep 4, 2026.
Financials
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $12.08M | $125.94M | — |
| Q1 FY2026ended Mar 31, 2026 | $84.81M | $67.72M | — |
| Q2 FY2025ended Jun 30, 2025 | $17.11M | −$69.47M | — |
| Q1 FY2025ended Mar 31, 2025 | $3.13M | −$28.65M | — |
About Apnimed
- Name
- Apnimed, Inc.
- Ticker
- APMD
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 39 John F. Kennedy Street, 4th Flr., Cambridge, MA 02138
- Incorporated in
- Delaware
- Fiscal year ends
- December
- SEC CIK
- 0001745648
Recent SEC filings
- Sep 8, 2026
- Sep 8, 2026
- Aug 3, 2026
Frequently asked questions
What is Apnimed's stock price?
Apnimed (APMD) closed at $491.84 on Oct 9, 2026, up 0.82% from the previous close of $487.86.
What is Apnimed's market cap?
Apnimed's market cap is $20.48B, based on a share price of $491.84 and 41.6M shares outstanding as of Sep 4, 2026.
Sources and methodology
Fundamentals come from Apnimed, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 10, 2026. Data sources and disclosures